NasdaqCM - Nasdaq Real Time Price USD
INmune Bio, Inc. (INMB)
7.87
-0.37
(-4.49%)
As of 9:38:42 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| JUDA SCOTT Director | Purchase | Jun 25, 2024 | -- |
| LOWDELL MARK WILLIAM Officer and Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2024 | 1,510,810 |
| MOSS DAVID J. Chief Financial Officer | Purchase | Sep 30, 2024 | 1,285,870 |
| SCHROEDER TIMOTHY J Director | Sale | Jul 12, 2023 | -- |
| TESI RAYMOND JOSEPH Chief Executive Officer | Purchase | Sep 12, 2024 | 1,554,110 |
Related Tickers
COYA Coya Therapeutics, Inc.
6.89
+4.97%
BDTX Black Diamond Therapeutics, Inc.
1.5600
-1.25%
GANX Gain Therapeutics, Inc.
1.8500
0.00%
AKRO Akero Therapeutics, Inc.
39.64
+0.06%
LXEO Lexeo Therapeutics, Inc.
3.2200
-4.45%
CMPX Compass Therapeutics, Inc.
2.0200
-2.42%
AVXL Anavex Life Sciences Corp.
9.38
+0.77%
ANVS Annovis Bio, Inc.
1.5005
-0.63%
ABEO Abeona Therapeutics Inc.
5.21
-0.15%
CRDF Cardiff Oncology, Inc.
2.9550
+0.51%